Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Senexin C

😃Good
Catalog No. T62702Cas No. 2375554-02-0

Senexin C is a novel orally active and specific CDK8/19 inhibitor with potential anticancer activity.Senexin C is more metabolically stable and potent than Senexin B. Senexin C inhibits the growth of MV4-11 leukaemia cells.

Senexin C

Senexin C

😃Good
Purity: 97.91%
Catalog No. T62702Cas No. 2375554-02-0
Senexin C is a novel orally active and specific CDK8/19 inhibitor with potential anticancer activity.Senexin C is more metabolically stable and potent than Senexin B. Senexin C inhibits the growth of MV4-11 leukaemia cells.
Pack SizePriceAvailabilityQuantity
1 mg178 €In Stock
5 mg454 €In Stock
10 mg777 €In Stock
25 mg1.605 €In Stock
50 mg2.745 €8-10 weeks
1 mL x 10 mM (in DMSO)501 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Senexin C"

Select Batch
Purity:97.91%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Senexin C is a novel orally active and specific CDK8/19 inhibitor with potential anticancer activity.Senexin C is more metabolically stable and potent than Senexin B. Senexin C inhibits the growth of MV4-11 leukaemia cells.
Targets&IC50
CDK8-CyclinC:3.6 nM, CDK8-CyclinC:1.4 nM (Kd), CDK8-CyclinC:2.9 nM (Kd)
In vitro
Senexin C exhibits high selectivity for CDK8 and CDK19, with similar Kd values of 55 nM and 44 nM respectively for ATP analog binding, while showing much higher Kd values for the other three non-target kinases (HASPIN: 1000 nM; MAP4K2: 940 nM; MYO3B: > 30,000 nM)[1].
In vivo
Tumor-bearing mice(CT26 tumor mode) received Senexin C via intravenous injection at 2.5 mg/kg or orally at 100 mg/kg, and compound concentrations in blood and tumors were measured by LC-MS/MS. The results indicated that Senexin C exhibits favorable tumor PK characteristics and low toxicity[1].
Chemical Properties
Molecular Weight449.55
FormulaC28H27N5O
Cas No.2375554-02-0
SmilesN#CC=1C=CC2=NC=CC(NCCC=3C=CC4=CC(=CC=C4C3)C(=O)N5CCN(C)CC5)=C2C1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 20 mg/mL (44.49 mM), Sonication and heating are recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2244 mL11.1222 mL22.2445 mL111.2223 mL
5 mM0.4449 mL2.2244 mL4.4489 mL22.2445 mL
10 mM0.2224 mL1.1122 mL2.2244 mL11.1222 mL
20 mM0.1112 mL0.5561 mL1.1122 mL5.5611 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Senexin C | purchase Senexin C | Senexin C cost | order Senexin C | Senexin C chemical structure | Senexin C in vivo | Senexin C in vitro | Senexin C formula | Senexin C molecular weight